| Name | Title | Contact Details |
|---|
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Cybba provides integrated marketing and advertising tools for eCommerce businesses to drive website traffic and increase onsite conversions.
Transcend Solutions is one of the top Staffing Agencies in the Pacific Northwest. We help top companies in the Pacific Northwest hire great people.
Dot Compliance is a company that provides a ready-to-use Quality Management Solution (QMS) powered by the Salesforce.com platform, specifically designed for the life science industry. Their cloud-based eQMS is compliant with FDA 21 CFR part 11 and buil...
UserLeap is the first continuous research platform that bridges the gap between traditional user research and analytics.